Standard Biotools (LAB) Revenue Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.92% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 17.14% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 7.43% |
| 10 | Standard Biotools | 344.96 Mn | -110.22 Mn | 11.31 Mn | -5.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.58% |
| Dec 31, 2025 | -4.15% |
| Sep 30, 2025 | -8.65% |
| Jun 30, 2025 | 5.04% |
| Mar 31, 2025 | -8.62% |
| Sep 30, 2024 | -8.15% |
| Jun 30, 2024 | -10.16% |
| Mar 31, 2024 | 11.57% |
| Dec 31, 2023 | -14.19% |
| Sep 30, 2023 | -13.99% |
| Jun 30, 2023 | 2.02% |
| Mar 31, 2023 | 100.85% |
| Dec 31, 2022 | -5.91% |
| Sep 30, 2022 | -1.08% |
| Jun 30, 2022 | -12.67% |
| Mar 31, 2022 | -4.16% |
| Sep 30, 2021 | -0.53% |
| Jun 30, 2021 | 5.48% |
| Mar 31, 2021 | 9.11% |
| Dec 31, 2020 | 17.15% |